Today (9/30) the U.S. Food and Drug Administration (FDA) granted clearance for leading visualizations for surgical procedures provider, SentiAr’s holographic cardiac ablation system Command EP. This will be the first holographic guidance system to be used in an invasive cardiac procedure. The product will give surgeons 3D, real-time visuals via a wearable headset and using SentiAR’s proprietary data flow and visualization algorithms, deliver precise performance and results. Command EP will be easily streamlined into electrophysiologists’ existing workflows and will revolutionize the way cardiac surgery is performed.

Read more here.

More on: